Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryRaySearch RayStation module that uses deep-learning segmentation models to generate radiation therapy contours inside the treatment-planning environment.
Cancer centers already using or evaluating RayStation that want AI segmentation tightly integrated with treatment planning and can commission site-specific review workflows.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating RayStation Deep Learning Segmentation as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as high-risk radiation oncology treatment-planning software and verify the exact RayStation release, 510(k) or local authorization, enabled model, modality, anatomy, and market restriction before production use. |
|---|---|
| Privacy | Review RayStation deployment architecture, image and contour storage, support access, scripting, logs, connected services, retention, BAA or data-processing terms, and whether model updates use customer data. |
| Evidence | Commission DLS performance by cancer site, scanner, protocol, contouring guideline, physician edit burden, abnormal anatomy, artifacts, and treatment-plan impact rather than relying only on vendor time-savings claims. |
| Workflow | Best governed as an integrated contouring and planning accelerator with radiation oncologist review, dosimetrist editing, physicist QA, documented exceptions, and manual fallback for unsupported cases. |
RaySearch describes machine-learning features in RayStation for automated plan generation and organ segmentation, with deep-learning segmentation models released with RayStation versions and subject to market-specific regulatory clearance; RaySearch's FDA clearance announcement and FDA 510(k) summary for RayStation 8.1 document machine-learning planning and segmentation functionality.
Not for: Unreviewed contour acceptance, autonomous treatment decisions, assuming dose-prediction claims apply in the U.S. or Canada, or use outside the cleared release, market, modality, and model catalogue.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.